Soleno Therapeutics, Inc. (SLNO)
52.57
0.00 (0.00%)
USD |
NASDAQ |
Apr 16, 16:00
52.58
+0.01
(+0.02%)
After-Hours: 20:00
Soleno Therapeutics Cash from Investing (Quarterly) : -125.36M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | -52.90M |
| Nektar Therapeutics | 0.372M |
| Boston Scientific Corp. | -512.00M |
| Integer Holdings Corp. | -35.47M |
| Molina Healthcare, Inc. | 230.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 48.70M |
| Cash from Financing (Quarterly) | -99.90M |
| Free Cash Flow | 46.66M |
| Free Cash Flow Per Share (Quarterly) | 0.8954 |
| Free Cash Flow to Equity (Quarterly) | 48.76M |
| Free Cash Flow to Firm (Quarterly) | 50.00M |
| Free Cash Flow Yield | 1.72% |